Beta-blockers (All routes except ocular) (versus unexposed) updated on 12-17-2024

Limb defects

R analysis
id Study   Lib. in paper Exposition period    Study type  Control type 
 
Tags OR 95%CI x1/n1 x0/n0 no cases no exposed ROB Ref.
S17127
R71756
Delteil - Beta-blockers, 2024 Musculoskeletal malformations 1st trimester retrospective cohort (claims database) unexposed (general population or NOS) Adjustment: No Indications Antihypertensive: Only chronic indication (hypertension or cardiac) 1.80 [0.74;4.34] C 5/974   475/165,775 480 974
ref
S13935
R54560
Vasilakis-Scaramozza - Beta-blockers, 2013 Limb anomalies, excluding clubfoot. 1st trimester retrospective cohort unexposed (general population or NOS) Adjustment: Yes Indications Antihypertensive: All hypertensions, any indications or not specified 6.40 [0.60;74.20] 2/215   1/682 3 215
ref
S13584
R52673
Queisser-Luft - Beta-blockers, 1996 Musculoskeletal system malformations throughout pregnancy nested case control unexposed (general population or NOS) Adjustment: No Indications Antihypertensive: All hypertensions, any indications or not specified 1.50 [0.20;11.00] -/-   0/- - -
ref
Total 3 studies 1.99 [0.92;4.28] 483 1,189
x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives

Forest plot

StudyTE95% CIn casesn exposedweightROBABCDEF Delteil - Beta-blockers, 2024Delteil - Beta-blockers, 2024 1.80[0.74; 4.34]48097475%ROB confusion: criticalROB selection: lowROB classification: criticalROB missing: lowROB mesure: moderateROB reporting: moderate Vasilakis-Scaramozza - Beta-blockers, 2013Vasilakis-Scaramozza - Beta-blockers, 2013 6.40[0.60; 74.20]321510%ROB confusion: seriousROB selection: moderateROB classification: criticalROB missing: unclearROB mesure: moderateROB reporting: moderate Queisser-Luft - Beta-blockers, 1996Queisser-Luft - Beta-blockers, 1996 1.50[0.20; 11.00]--15%ROB confusion: criticalROB selection: lowROB classification: criticalROB missing: unclearROB mesure: moderateROB reporting: critical Total (3 studies) I2 = 0% 1.99[0.92; 4.28]4831,1890.520.01.0ROB: A: confusion, B: selection, C: classification, D: missing, E: measurement, F: reportinglow,moderate,serious,critical,unclear,

Sensitivity analysis

SubsetTE95% CIn casesn exposedkI2 Type of studies cohort studiescohort studies 2.09[0.91; 4.78]4831,1890%NADelteil - Beta-blockers, 2024 Vasilakis-Scaramozza - Beta-blockers, 2013 2 case control studiescase control studies 1.50[0.20; 11.12]-- -NAQueisser-Luft - Beta-blockers, 1996 1 Type of controls unexposed (disease free or unspecified)unexposed (disease free or unspecified) 1.99[0.92; 4.28]4831,1890%NADelteil - Beta-blockers, 2024 Vasilakis-Scaramozza - Beta-blockers, 2013 Queisser-Luft - Beta-blockers, 1996 3 Tags Adjustment   - No  - No 1.74[0.78; 3.91]4809740%NADelteil - Beta-blockers, 2024 Queisser-Luft - Beta-blockers, 1996 2   - Yes  - Yes 6.40[0.58; 71.17]3215 -NAVasilakis-Scaramozza - Beta-blockers, 2013 1 Indications Antihypertensive   - All hypertensions, any indications ...  - All hypertensions, any indications or not specified 2.71[0.58; 12.67]32150%NAVasilakis-Scaramozza - Beta-blockers, 2013 Queisser-Luft - Beta-blockers, 1996 2   - Only chronic indication (hypertensi ...  - Only chronic indication (hypertension or cardiac) 1.80[0.74; 4.34]480974 -NADelteil - Beta-blockers, 2024 1 All studiesAll studies 1.99[0.92; 4.28]4831,1890%NADelteil - Beta-blockers, 2024 Vasilakis-Scaramozza - Beta-blockers, 2013 Queisser-Luft - Beta-blockers, 1996 30.520.01.0

Publication bias and p-hacking diagnosis

funnel plot

Funnel plot not drawn. Less than 3 points.

Asymetry test p-value = NaN (by Egger's regression)

not enought points

p values plot

Funnel plot not drawn. Less than 3 points.

Sub-groups analysis using all included studies

excluded

Sub-groupsTE95% CIn casesn exposedkI2ROB type of controls unexposed controls (disease free or unspecified)unexposed controls (disease free or unspecified) 1.99[0.92; 4.28]4831,1890%NADelteil - Beta-blockers, 2024 Vasilakis-Scaramozza - Beta-blockers, 2013 Queisser-Luft - Beta-blockers, 1996 30.510.01.0